Coegin Pharma AB (NGM:COEGIN)
Sweden · Delayed Price · Currency is SEK 3.710
-0.040 (-1.07%)
At close: Mar 6, 2026
Coegin Pharma AB Revenue
In the year 2025, Coegin Pharma AB had annual revenue of 372.00K SEK. Coegin Pharma AB had revenue of 112.00K in the quarter ending December 31, 2025.
Revenue
372.00K
Revenue Growth
n/a
P/S Ratio
1,168.30
Revenue / Employee
26.33K
Employees
3
Market Cap
92.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 372.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valuno Group AB | 2.19B |
| Spotlight Group AB | 114.42M |
| Mediacle Group AB | 47.81M |
| Amido AB | 44.95M |
| Ramlösa shipping AB | 39.85M |
| ODI Pharma AB | 20.04M |
| Nowonomics AB | 19.10M |
| Railway Metrics and Dynamics Sweden AB | 13.62M |